发明名称 Immunogenic composition
摘要 The invention provides immunogenic polysaccharide protein conjugates comprising capsular polysaccharides from N. Meningitidis serogroup X and methods for preparation thereof. The present invention relates to N. meningitidis X saccharide-carrier protein conjugates prepared by a conjugation reaction. Accordingly, the instant invention relates to multivalent meningococcal polysaccharide protein conjugate composition comprising capsular saccharide from serogroups X and at least one capsular saccharide from A, C, W135 and Y wherein, i) polysaccharides A C W135 X are sized mechanically whereas polysaccharide Y is sized chemically, ii) all saccharide are conjugated to carrier protein via a linker with a cyanylation conjugation chemistry iii) all saccharide to protein ratios in final conjugates are between 0.2-0.6 and iv) at least two different carrier proteins selected from the group consisting of TT, DT and CRM197 are utilized.
申请公布号 US9198977(B2) 申请公布日期 2015.12.01
申请号 US201314375385 申请日期 2013.01.29
申请人 Serum Institute of India Ltd. 发明人 Kapre Subhash Vinayak;Pisal Sambhaji Shankar
分类号 A61K39/00;A61K39/02;A61K39/095;A61K39/385;A61K47/48 主分类号 A61K39/00
代理机构 Knobbe, Martens, Olson & Bear, LLP 代理人 Knobbe, Martens, Olson & Bear, LLP
主权项 1. An immunogenic composition comprising (a) a conjugate of (i) the capsular saccharide of serogroup A N. meningitidis and (ii) tetanus toxoid; (b) a conjugate of (i) capsular saccharide of serogroup C N. meningitidis and (ii) CRM197; (c) a conjugate of (i) capsular saccharide of serogroup Y N. meningitidis and (ii) CRM197; (d) a conjugate of (i) capsular saccharide of serogroup W135 N. meningitidis and (ii) CRM197; and (e) a conjugate of (i) capsular saccharide of serogroup X N. meningitidis and (ii) tetanus toxoid wherein the N. meningitidis X polysaccharide-protein conjugate is derived from N. meningitidis X strain 8210, 9601, 9592, 9554 or 2526.
地址 Pune IN